Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,125.00    -7.50 (-0.66%)
Bid:
1,131.00
Ask:
1,131.50
Spread: 0.50 (0.044%)
Market Cap: £9.53b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

24 May 2022 14:30

RNS Number : 6442M
Smith & Nephew Plc
24 May 2022
 

SMITH & NEPHEW PLC

 

24 May 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF A CONDITIONAL AWARD GRANTED UNDER AN AWARD AGREEMENT DATED 29 APRIL 2022

 

On 23 May 2022, the Conditional Award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested over 70,378 Shares. The resultant Shares post-vest were sold on 23 May 2022. Proceeds from the sale of sufficient Shares were utilised to satisfy the taxes due. As previously announced the Conditional Award formed part of buy-out awards in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Vesting of a Conditional Award and subsequent sale of all Shares.

Date of Transaction

2022 - 05 - 23

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

12.743100

70,378 (of which 70,378 were sold and 0 retained)

N/A Single Transaction

0.00000 ordinary shares

0.00000%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

2. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010

 

On 23 May 2022, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010.

 

i. FINAL VESTING ON 23 MAY 2022 OF CONDITIONAL SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

The awards were granted under the Global Share Plan 2010 on 23 May 2019. One third of the shares vested on 23 May 2020, a further third vested on 23 May 2021 and the final third vested on 23 May 2022. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Final vesting of a Conditional Share Award granted on 23 May 2019 under the Smith & Nephew Global Share Plan 2010.

Date of Transaction

2022 - 05 - 23

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Myra Eskes

(President APAC Region)

PDMR

12.8275

8,571 (of which 0 were sold and 8,571 retained)

N/A Single Transaction

27,183.09703 ordinary shares

0.00307%

 

Simon Fraser

(President, Advanced Wound Management and Global Commercial Operations)

PDMR

12.8275

2,600 (of which 1,027 were sold and 1,573 retained)

N/A Single Transaction

27,398.81838 ordinary shares

0.00310%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFVERISFIF
Date   Source Headline
15th Feb 20185:43 pmRNSTransaction in Own Shares
14th Feb 20186:10 pmRNSTransaction in Own Shares
13th Feb 20184:11 pmRNSDirector/PDMR Shareholding
12th Feb 20189:15 amRNSTransaction in Own Shares
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018
4th Oct 20178:00 amRNSWound Expert Panel Report
2nd Oct 201710:24 amRNSTotal Voting Rights
2nd Oct 20179:00 amRNSDirectorate Change
18th Sep 20179:42 amRNSDirectorate Change
12th Sep 20174:45 pmRNSDirector/PDMR Shareholding
12th Sep 20172:18 pmRNSAdditional Listing
12th Sep 201711:30 amRNSDirectorate Change
5th Sep 20178:00 amRNSSmith & Nephew and Imperial College Partnership
1st Sep 201712:42 pmRNSTotal Voting Rights
16th Aug 20174:54 pmRNSDirector/PDMR Shareholding
15th Aug 20174:38 pmRNSDirector/PDMR Shareholding
14th Aug 20174:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20175:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.